Public Health Physician and Urban Epidemiologist, The Principal of Oni et al. and founder of UrbanBetter.
Born in Lagos, she completed her medical training at University College London, a Masters degree in Public Health at the University of Cape Town and a doctorate in Epidemiology at Imperial College London, UK.
Tolullah Oni, a Public Health Physician and urban epidemiologist is the Principal of Oni et al. and founder of UrbanBetter. She is an Honorary Associate Professor and lead of the Research Initiative for Cities Health and Equity (RICHE) group at the University of Cape Town and a Clinical Senior Research Associate / Joint Lead of the Global Health Research Group at the University of Cambridge MRC Epidemiology Unit.
Born in Lagos, she completed her medical training at University College London, a Masters degree in Public Health at the University of Cape Town and a doctorate in Epidemiology from Imperial College London, UK.
Profiled in the Lancet journal, Science magazine, and the British Medical Journal, she is a Fellow of the African Academy of Sciences, past co-chair of the Global Young Academy and the South African Young Academy of Science, 2015 Next Einstein Forum Fellow, 2019 World Economic Forum Young Global Leader, and a 2020 Next Generation Foresight Practitioner Fellow.
Her global practice is grounded in a science-informed, Africa-led, health foresight approach to generating new knowledge that supports partnership between science, policy and societal role players. She is passionate about identifying creative strategies to address complex urban population health challenges in rapidly growing cities globally.
Want to see more on the work of UrbanBetter and Oni et al.?
Disruptors we admire
We celebrate young African disruptors from all corners of the world, at the forefront of building healthy and sustainable places for people and planet. These are some of the people impatient for impact, whose actions inspire us.
Dr. Ebele Mogo
Ebele is passionate about creating solutions that can change the trajectory of health and wellbeing, especially in Africa.
Some of her past work includes frontline engagement of clinicians in the roll-out of a state-wide medical waste management initiative in Lagos, Nigeria; co-developing a malaria prevention initiative focused on Nkolve, Cameroon; an internship at the WHO investigating factors shaping urban health in Lagos, and leading Africa-wide partnerships for a digital health innovation.
She leads Engage Africa Foundation, a pan-African network on a mission to advocate for people-centred solutions that put health at the center of development in Africa, in light of the rise of non-communicable diseases. They have run dialogues with the Young Town Planners Association of the Nigerian Institute of Town planners on the connection between planning and health. More recently, they ran a crowdsourced digital campaign where over thirty young people participated in translating the WHO’s preventive guidelines on COVID-19 into 19 African languages. She is also a writer and her work has been featured in Johnson and Johnson’s Africa Storytelling Challenge. In recognition of her contributions to health science, she was selected to the 2020 Next Einstein Fellowship.
Tola aims to disrupt health inequality in Africa‘s cities by harnessing the power of data science, epidemiology and machine learning to explore and model various diseases and risk factors in order to better understand and minimize disparities in urban health.
She is a Master of Public Health graduate from the University of Queensland, Australia, and has completed a BSc.Double Major in Biology and Medical Science from the University of Western Ontario, Canada. Her experience includes research and community outreach with organizations targeting urban slum populations, women, children, and youth across Nigeria, Canada, and Australia. Omotola leads policy research and partnership building at the Engage Africa Foundation, where she worked on research recommending a shift to a socioecological response to effectively tackle rising non-communicable disease in Africa’s cities.